Middle East & Africa Structural Heart Market Forecast to 2028

Middle East & Africa Structural Heart Market Forecast to 2028 – Regional Analysis – by Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)

Send Enquiry
Item ID: BMIRE00028945 Category: Tags: , ,

$2,100$3,500

Description

The Middle East & Africa structural heart market is expected to grow from US$ 643.90 million in 2022 to US$ 927.25 million by 2028. It is estimated to grow at a CAGR of 6.3% from 2022 to 2028.

Growing Use of Artificial Intelligence in Structural Heart Fuel Middle East & Africa Structural Heart Market

The number of interventional structural heart disease (SHD) procedures, such as transcatheter valve procedures, has increased significantly in recent years, triggering the need for well-founded knowledge about optimal anatomical spatial orientation during these procedures. This has led to the development of new procedural capabilities and technologies in periprocedural planning. Hybrid fusion imaging (FI) combines multiple imaging modalities, mainly based on multislice spiral computed tomography (MSCT) and echocardiography, with fluoroscopy. Ongoing developments in machine learning and artificial intelligence (AI) facilitate the routine use of individualized segmented 3D heart models that allow for multiple combinations of different imaging modalities. As AI enables computers to perform tasks at a greater speed and with potentially better precision than humans, risk stratification and outcome aspects can be optimized in the future. The application of computer modeling, 3D printing, and AI has already led to transformations in procedure planning and physician education on SHD. These technologies also promise unlimited possibilities. With further research and development, AI can advance precision medicine at every step, including diagnosis, treatment stratification and device selection, procedure delivery and guidance, and post-procedure/discharge monitoring and rehabilitation. The prevalence of cardiovascular diseases is rising worldwide. The structural heart market is at the initial stage of development in regions such as the Middle East and Africa.

Most of the people in this region chew or smoke tobacco, and the incidence of structural heart disease is increasing in this region. According to the American Heart, cardiovascular diseases caused ~19.1 million deaths worldwide in 2020. Thus, with the rising incidence of structural heart diseases in the abovementioned regions, the market players are likely to grab significant opportunities to offer effective products.

Middle East & Africa Structural Heart Market Overview

The Middle East & Africa structural heart market is estimated to grow at a CAGR of 6.3% from 2022 to 2028. Key factors driving the market growth are availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs. However, high cost of procedure followed by stringent regulations regarding structure heart device are the major factors hampering the growth of the market.

Middle East & Africa Structural heart Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Structural Heart Market Segmentation

The Middle East & Africa structural heart market is segmented into product, procedure, end user, and country.

Based on product, the Middle East & Africa structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on procedure, the Middle East & Africa structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on end user, the Middle East & Africa Structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on country, the Middle East & Africa structural heart market is segmented into the Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, and Edwards Lifesciences Corp are some of the leading companies operating in the Middle East & Africa structural heart market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 6.3% CAGR, the Middle East & Africa Structural Heart Market is Speculated to be Worth US$ 927.25 million by 2028, says Business Market Insights

According to Business Market Insights research, the Middle East & Africa structural heart market was valued at US$ 643.90 million in 2022 and is expected to reach US$ 927.25 million by 2028, registering a CAGR of 6.3% from 2022 to 2028. Availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs are the factors attributed to the Middle East & Africa structural heart market expansion.

Transcatheter procedures lead to improvements in patients’ heart conditions in shorter a period compared to surgical intervention. In addition, minimally invasive procedures have reduced surgical and cardiopulmonary risks, which results in increased patient satisfaction. TAVR has gathered more attention due to its ability to offer a reasonable option for the treatment of degenerative aortic stenosis. Moreover, the recent developments in structural heart devices focus on indications, and results of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. A few of the technological advancements by the players in the Middle East & Africa Structural heart market. In February 2023, Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired RVOT. Evolut FX added new features to the existing Evolut platform to enhance ease of use and predictable valve deployment for physicians. In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution, for the treatment of structural heart disease. Echo Navigator 4.0 provides the users of Philips’ EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company’s Image Guided Therapy System called “Azurion – platform.” In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform. In August 2021, CORCYM enrolled the first patient in the Mitral, Aortic, and Tricuspid Post-Market Study in a Real-World Setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve. Therefore, technological advancements are leading to new growth trends in the Middle East & Africa Structural heart market growth.

On the contrary, high cost of procedures systems hampers the Middle East & Africa structural heart market.

Based on product, the Middle East & Africa structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held 40.4% share of Middle East & Africa structural heart market in 2022, amassing US$ 259.83 million. It is projected to garner US$ 379.58 million by 2028 to expand at 6.5% CAGR during 2022-2028.

Based on procedure, the Middle East & Africa structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held 45.3% share of Middle East & Africa structural heart market in 2022, amassing US$ 291.81 million. It is projected to garner US$ 405.10 million by 2028 to expand at 5.6% CAGR during 2022-2028.

Based on end user, the Middle East & Africa structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 49.3% share of Middle East & Africa structural heart market in 2022, amassing US$ 317.50 million. It is projected to garner US$ 468.00 million by 2028 to expand at 6.7% CAGR during 2022-2028.

Based on country, the Middle East & Africa structural heart market has been categorized into Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa. Our regional analysis states Saudi Arabia that the captured 40.5% share of Middle East & Africa structural heart market in 2022. It was assessed at US$ 260.84 million in 2022 and is likely to hit US$ 391.58 million by 2028, exhibiting a CAGR of 7.0% during 2022-2028.

Key players operating in the Middle East & Africa structural heart market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, and Edwards Lifesciences Corp, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Structural Heart Market – by Product
1.3.2 Middle East & Africa Structural Heart Market – by Procedure
1.3.3 Middle East & Africa Structural Heart Market – by End User
1.3.4 Middle East & Africa Structural Heart Market – by Country
2. Middle East & Africa Structural Heart Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Structural Heart Market – Market Landscape
4.1 Overview
4.1.1 Middle East & Africa PEST Analysis
4.2 Expert’s Opinion
5. Middle East & Africa Structural Heart Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. Middle East & Africa Structural Heart Market – Middle East & Africa Analysis
6.1 Middle East & Africa Structural Heart Market Revenue Forecast and Analysis
7. Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 Middle East & Africa Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 – by Procedure
8.1 Overview
8.2 Middle East & Africa Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Middle East & Africa Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Middle East & Africa Structural Heart Market
10.1.1 Overview
10.1.1.1 Saudi Arabia: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Saudi Arabia: Middle East & Africa Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.1.1.4 Saudi Arabia: Middle East & Africa Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.1.1.4.1 Saudi Arabia: Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.1.1.4.2 Saudi Arabia: Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.1.1.5 Saudi Arabia: Middle East & Africa Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.1.2 UAE: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UAE: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 UAE: Middle East & Africa Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.1.2.4 UAE: Middle East & Africa Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.1.2.4.1 UAE: Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.1.2.4.2 UAE: Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.1.2.5 UAE: Middle East & Africa Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.1.3 South Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa: Middle East & Africa Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.1.3.4 South Africa: Middle East & Africa Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.1.3.4.1 South Africa: Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.1.3.4.2 South Africa: Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.1.3.5 South Africa: Middle East & Africa Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.1.3.5.1 South Africa Middle East & Africa Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
10.1.1.4 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Structural Heart Market, by End User, 2019-2028 (USD Million)
11. Middle East & Africa Structural Heart Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Saudi Arabia Middle East & Africa Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 2. Saudi Arabia Middle East & Africa Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 3. Saudi Arabia Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 4. Saudi Arabia Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 5. Saudi Arabia Middle East & Africa Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 6. UAE Middle East & Africa Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 7. UAE Middle East & Africa Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 8. UAE Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 9. UAE Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 10. UAE Middle East & Africa Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 11. South Africa Middle East & Africa Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 12. South Africa Middle East & Africa Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 13. South Africa Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 14. South Africa Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 15. Rest of Middle East & Africa Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 16. Rest of Middle East & Africa Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 20. Recent Organic Growth Strategies in Middle East & Africa Structural Heart Market
Table 21. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Structural Heart Market Segmentation
Figure 2. Middle East & Africa Structural Heart Market, by country
Figure 3. Middle East & Africa Structural Heart Market Overview
Figure 4. Occluders Segment Held Largest Share of Product Segment in Middle East & Africa Structural Heart Market
Figure 5. Middle East & Africa: PEST Analysis
Figure 6. Middle East & Africa Experts’ Opinion
Figure 7. Middle East & Africa Structural Heart Market: Impact Analysis of Drivers and Restraints
Figure 8. Middle East & Africa Structural Heart Market – Revenue Forecast and Analysis – 2019-2028
Figure 9. Middle East & Africa Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
Figure 10. Occluders: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Annuloplasty Rings: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Heart Valve Balloons: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Middle East & Africa Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
Figure 15. Heart Valve Stenosis: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Heart Valve Regurgitation: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Left Atrial Appendage Closure: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Middle East & Africa Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
Figure 19. Hospitals: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Cardiac Centers: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Middle East & Africa: Middle East & Africa Structural Heart Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. Middle East & Africa: Middle East & Africa Structural Heart Market, by Country, 2021 & 2028 (%)
Figure 24. Saudi Arabia: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. UAE: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East & Africa: Middle East & Africa Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Middle East & Africa Structural Heart Market

– Abbott Laboratories
– Medtronic Plc
– Boston Scientific Corp
– Artivion Inc
– Edwards Lifesciences Corp

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Structural Heart Market Forecast to 2028”